Vivo Opportunity, LLC is 10% Owner at InMed Pharmaceuticals Inc. (INM). They have made 4 open-market trades across 2 companies since 2024, most recently 2026-07-16.
CIK 0001728970
3 open-market purchases totalling $434K since 2026, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLNO | 6,391,851 | $338.7M |
| SRRA | 431,947 | $23.8M |
| TERN | 268,573 | $14.2M |
| INM | 75,019 | $101K |
| Total | $376.8M |
Shares reported on the most recent Form 4, priced at the 2026-07-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INM | BUY | 2026-07-14 | 2026-07-16 | $1.55 | $32K | +8.2% | -7.6% | -15.2% |
| INM | BUY | 2026-06-30 | 2026-07-02 | $1.55 | $10K | +0.3% | -7.6% | -15.2% |
| INM | BUY | 2026-05-20 | 2026-06-10 | $1.57 | $392K | -5.0% | +3.8% | -15.1% |
| SLNO | SELL | 2024-08-27 | 2024-08-29 | $48.01 | $49.2M | +4.7% | +8.8% | +20.3% |
| TERN | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $6.71 | $4.9M | -16.6% | -10.4% | +10.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.